Cannabis Report in text over top a photo of cannabis leaves
(Source: File)

Pharmaceutical company MediPharm Labs Corp., specializing in precision-based cannabinoids, has launched the new Shake & Puff CBN THC Nighttime Inhaler in Canada. This product expands MediPharm’s CBN oil product portfolio and builds on the success of the Company’s THC Inhaler introduced earlier this year.

MediPharm Labs - MediPharm Labs Australia facility.
Source: MediPharm Labs.

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | MTL Cannabis reports Q4 and record full year 2025 financial results

2 | Leef Brands announces C$1 million private placement

3 | 1933 Industries holds important annual general meeting today

Top Cannabis Stocks July 18 to July 24, 2025

1. T.TLRY | 7,634 views | Tilray Brands Inc.
2. T.CURA | 6,198 views | Curaleaf Holdings Inc.
3. T.LABS | 3,443 views | Medipharm Labs Corp.
4. T.WEED | 2,554 views | Canopy Growth Corp.
5. T.ACB | 705 views | Aurora Cannabis Inc.
6. C.TGIF | 549 views | 1933 Industries Inc.


The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional.


More From The Market Online
The Market Online Video

Markets in Motion: Indicators steady as risk appetite holds

In this week’s Market in Motion, Bruce Campbell reviews strong market indicators, the Fed’s rate cut, positioning risks around AI and mega-cap stocks, and…

@ the Bell: Cannabis shares surge, Warner Bros. rejects Paramount for Netflix

Canada’s main stock index flatlined on Wednesday, thanks to a rise in commodity prices, including a...

Market Open: Warner Bros Rejects Paramount Bid, CPP Investments Partners with Dream | Dec 17

TSX falls 0.70%, Nasdaq gains 0.47%, oil climbs 1.65%, gold near record. CPP Investments forms JV as Warner Bros rejects Paramount bid.